Grant: Engage Grants Program
University of British Columbia
$25,000.00
Development of a capture device replacing filtration and purification processes used in USEPA 1623 method
FY 2012-13
Summary
Hyperion Research Ltd. is a well-known Canadian company analyzing drinking water samples for detection of
the presence of waterborne pathogens like Cryptosporidium. The company currently uses the United States
Environmental Protection Agency (EPA) Method 1623. This method involves three steps: i) sampling using
filtration which concentrates the pathogen , ii) purification based on the Immunomagnetic Separation (IMS)
technique which uses super-paramagnetic beads coated with ligand molecules specific to the target pathogen,
and iii) detection using epifluorescence microscopy. Although the EPA 1623 method has been accepted and
practiced as the standard method to detect Cryptosporidium, it is complex and requires highly-skilled
personnel. Also, a wide range of recovery efficiency with very poor reproducibility has been reported for this
method. Finally, the detection efficiency of the method can be adversely affected by increasing turbidity which
affects both the filtration and IMS purification steps. The company is now interested in using a technology
which is more cost-effective and reliable in capturing of Cryptosporidium, and at the same time less time and
labor intensive. In this project and in full collaboration with Hyperion, a capture device will be developed to
replace the existing filtration and purification processes of the EPA 1623 method. The proposed capture device
seizes the pathogens using antibodies (specific to the target pathogen) immobilized on the gold-coated
electrode, and pulsed-electric field. The latter is used to accelerate the motion of the pathogens toward the
antibodies while allowing the flow of water to wash away other charged particles from the surface, leaving only
the seized pathogens. After sampling, the pathogens can be released from the surface of the electrode by a pH
change and detected using epifluorescence microscopy. The combination of the pulsed electric field and
antibodies guarantees high recovery efficiency for the target pathogen (i.e., Cryptosporidium in this case) even
in turbid water samples. Development of such a device will have the potential to outclass the conventional
testing methods and bring a new perspective to the pathogen detection research.
Program
Engage Grants Program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
431152-2012
Name nom
Hoorfar, Mina
Department département
Okanagan - Engineering, School of
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
702
Area of application group en
Transportation systems and services
Area of application group fr
Services et systèmes de transport
Area of application en
Water
Area of application fr
Maritime
Research subject code
1500
Research subject group en
Environmental engineering
Research subject group fr
Génie de l'environnement
Research subject en
Environmental engineering
Research subject fr
Génie de l'environnement
Partie
1
Nb partie
1
Application title
Development of a capture device replacing filtration and purification processes used in USEPA 1623 method
Keyword
NSERC
Application summary
Hyperion Research Ltd. is a well-known Canadian company analyzing drinking water samples for detection of
the presence of waterborne pathogens like Cryptosporidium. The company currently uses the United States
Environmental Protection Agency (EPA) Method 1623. This method involves three steps: i) sampling using
filtration which concentrates the pathogen , ii) purification based on the Immunomagnetic Separation (IMS)
technique which uses super-paramagnetic beads coated with ligand molecules specific to the target pathogen,
and iii) detection using epifluorescence microscopy. Although the EPA 1623 method has been accepted and
practiced as the standard method to detect Cryptosporidium, it is complex and requires highly-skilled
personnel. Also, a wide range of recovery efficiency with very poor reproducibility has been reported for this
method. Finally, the detection efficiency of the method can be adversely affected by increasing turbidity which
affects both the filtration and IMS purification steps. The company is now interested in using a technology
which is more cost-effective and reliable in capturing of Cryptosporidium, and at the same time less time and
labor intensive. In this project and in full collaboration with Hyperion, a capture device will be developed to
replace the existing filtration and purification processes of the EPA 1623 method. The proposed capture device
seizes the pathogens using antibodies (specific to the target pathogen) immobilized on the gold-coated
electrode, and pulsed-electric field. The latter is used to accelerate the motion of the pathogens toward the
antibodies while allowing the flow of water to wash away other charged particles from the surface, leaving only
the seized pathogens. After sampling, the pathogens can be released from the surface of the electrode by a pH
change and detected using epifluorescence microscopy. The combination of the pulsed electric field and
antibodies guarantees high recovery efficiency for the target pathogen (i.e., Cryptosporidium in this case) even
in turbid water samples. Development of such a device will have the potential to outclass the conventional
testing methods and bring a new perspective to the pathogen detection research.